title: Controversies in medical management of intracerebral hemorrhage.
abstract: Intracerebral hemorrhage (ICH) is a devastating form of stroke that is associated with a very high mortality rate. Both medical therapies to control blood pressure, blood sugar, temperature, and surgical therapies to remove or contain clot remain controversial. The decision when to offer medical versus surgical treatment is very challenging and uncertain. Novel therapies are currently being developed and may be successful in containing the neurological injury associated with ICH. This review will highlight the controversies underlying medical management of ICH and the current ongoing research in the field.
authors.affiliation: Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, Rm 1242A, 1403 29th Street N.W., Calgary, Alberta, T2N 2T9, Canada.
authors.forename: Suresh
authors.initials: S
authors.lastname: Subramaniam
authors.forename: Michael D
authors.initials: MD
authors.lastname: Hill
mesh_terms: D002543:Cerebral Hemorrhage / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D011379:Prognosis
chemical_list: D006490:Hemostatics